CVE-2012-0313
Summary
| CVE | CVE-2012-0313 |
|---|---|
| State | PUBLISHED |
| Assigner | jpcert |
| Source Priority | CVE Program / NVD first with legacy fallback |
| Published | 2012-01-24 04:03:36 UTC |
| Updated | 2026-04-29 01:13:23 UTC |
| Description | Cross-site scripting (XSS) vulnerability in glucose 2 before stage 6.2 allows remote attackers to inject arbitrary web script or HTML via an RSS feed. |
Risk And Classification
CVSS v2.0 Breakdown
Access Vector
NetworkAccess Complexity
MediumAuthentication
NoneConfidentiality
NoneIntegrity
PartialAvailability
NoneAV:N/AC:M/Au:N/C:N/I:P/A:N
NVD Known Affected Configurations (CPE 2.3)
Vendor Declared Affected Products
References
| Reference | Source | Link | Tags |
|---|---|---|---|
| JVN#65869891: glucose 2 vulnerable to arbitrary script execution | af854a3a-2127-422b-91ae-364da2661108 | jvn.jp | |
| jvndb.jvn.jp/jvndb/JVNDB-2012-000008 | af854a3a-2127-422b-91ae-364da2661108 | jvndb.jvn.jp | |
| glucose : glucose 2 stage 6.2 | af854a3a-2127-422b-91ae-364da2661108 | glucose.jp | Vendor Advisory |
| CVE Program record | CVE.ORG | www.cve.org | canonical |
| NVD vulnerability detail | NVD | nvd.nist.gov | canonical, analysis |
No vendor comments have been submitted for this CVE.
There are currently no legacy QID mappings associated with this CVE.